# Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma

> **NCT02549833** · PHASE1 · COMPLETED · sponsor: **Jennie Taylor** · enrollment: 28 (actual)

## Conditions studied

- Oligodendroglioma
- Astrocytoma, Grade II
- Glioma, Astrocytic
- Glioma
- Malignant Glioma
- Oligoastrocytoma, Mixed

## Interventions

- **BIOLOGICAL:** GBM6-AD and poly-ICLC before and after surgery
- **BIOLOGICAL:** GBM6-AD and poly-ICLC after surgery only

## Key facts

- **NCT ID:** NCT02549833
- **Lead sponsor:** Jennie Taylor
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-17
- **Primary completion:** 2022-08-15
- **Final completion:** 2024-08-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549833, "Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02549833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*